| Gennex Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.01 | 0.09 | 0.21 | 0.16 | 0.14 |
| Long Term Debt-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 5.16 | 2.95 | 1.94 | 1.78 | 1.63 |
| Fixed Assets | 2.22 | 2.26 | 2.14 | 2.10 | 1.99 |
| Inventory | 4.77 | 6.28 | 10.23 | 10.22 | 9.39 |
| Debtors | 6.61 | 7.09 | 6.44 | 8.36 | 7.19 |
| Interest Cover Ratio | 13.72 | 5.89 | 6.78 | 7.84 | 4.40 |
| PBIDTM (%) | 22.59 | 11.20 | 10.36 | 10.49 | 7.17 |
| PBITM (%) | 21.50 | 10.16 | 9.15 | 9.11 | 5.50 |
| PBDTM (%) | 21.03 | 9.47 | 9.01 | 9.33 | 5.92 |
| CPM (%) | 17.03 | 7.43 | 7.22 | 7.73 | 4.77 |
| APATM (%) | 15.94 | 6.39 | 6.01 | 6.35 | 3.10 |
| ROCE (%) | 12.50 | 10.69 | 11.78 | 13.17 | 8.31 |
| RONW (%) | 9.45 | 7.41 | 9.35 | 10.67 | 5.33 |